AI assistant
Sending…
Equinor — Investor Presentation 2014
Sep 12, 2014
3597_iss_2014-09-12_61a9e021-aaf6-4a71-9e00-3204d8e61718.pdf
Investor Presentation
Open in viewerOpens in your device viewer
high grade NCS portfolio 12 September 2014
Demonstrating value of NCS portfolio
- USD 1.3 billion consideration, including a USD 50 million contingent payment
- − Contingency is linked to Aasta Hansteen milestones
- Create value through portfolio adjustments
- − Maintain operatorship and a 51 % equity share in the strategic Aasta Hansteen gas development
- − Early monetisation on development projects
- − Exiting non-core assets on NCS
- − Farm-down exploration licences
- Reducing capex commitments
- ~ USD 1.8 bn for the period from the effective date until end of 2020
- Continue partnership with Wintershall on NCS
- − Wintershall joins Aasta Hansteen, a key gas development underpinning the next decade of Norwegian gas exports
- − AMI related to future licence rounds agreed
- − MoU on EOR research cooperation
A continuation of our value driven portfolio strategy
Capture value from field development projects
- Exit non-core Vega and Gjøa
-
Transferring Vega operatorship to Wintershall, a core investor and operator in the region
-
Early monetisation of Aasta Hansteen area development project
- Balancing equity share while maintaining operatorship
- Release of around 3 bn of capital in form Increase flexibility of upfront consideration and future capex
Strong track record of value creating transactions
Realised ~USD 20 bn in proceeds and delivered ~USD 10 bn in capital gains
Proceeds (USD bn), main divestments 2009-2014
1) * At effective date. Accounting gain expected within the range of USD 0.7-0.9 billion. Deal is subject to closing.
4 2) Proceeds based on transaction year
More from Equinor
Regulatory Filings
2026
May 21
Notice of Dividend Amount
2026
May 21
Notice of Dividend Amount
2026
May 21
Director's Dealing
2026
May 20
Director's Dealing
2026
May 20
Director's Dealing
2026
May 20
Director's Dealing
2026
May 20
Director's Dealing
2026
May 20
Director's Dealing
2026
May 20
Regulatory Filings
2026
May 20